Kalvista Pharmaceuticals Inc (KALV) stock news · rev $49.1M
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
This KALV news page leads with what Kalvista Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for KALV yet. We will not pad this page with generic market recap.
Latest reported KALV revenue for 2025-12-31 was $49.1M. Net income was -$109.5M. Revenue was down 1.8% from 2024-04-30 to 2025-12-31. KALV currently screens at market cap $1.44B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KALV stock page; for the tape open the quote page.
KALV stock news FAQ
What are KALV's latest revenue and net income?
Latest cached Kalvista Pharmaceuticals Inc (KALV) revenue for Dec 31, 2025 was $49.1M. Net income was -$109.5M. Statements: https://lician.com/financials/kalv
How did KALV revenue change from the prior cached period?
Cached Kalvista Pharmaceuticals Inc (KALV) revenue was down 1.8% from $50.0M (Apr 30, 2024) to $49.1M (Dec 31, 2025). Statements: https://lician.com/financials/kalv
What is KALV's market cap?
Kalvista Pharmaceuticals Inc (KALV) market cap is $1.44B on the latest cached fundamentals snapshot.
What kind of company is KALV?
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Where is KALV stock news listed?
Cached stock news for Kalvista Pharmaceuticals Inc (KALV) is listed at https://lician.com/news/kalv. Filings: https://lician.com/sec/kalv
Not investment advice.